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ABSTRACT: Osteoarthritis (OA) is generally a disease of the elderly population, but can occur in young patients in exceptional cases. This
study compares the cellular and epigenetic features of primary old-age OA with those of secondary OA in a 23-year-old patient with
developmental dysplasia of the hip. In addition, control cartilage from a 14-year-old was compared with that from patients with a fracture of
the neck of femur (#NOF) to establish to what extent the latter is a useful control for OA. Articular cartilage was obtained from discarded
femoral heads after hip arthroplasty. MMP-3, MMP-9, MMP-13, and ADAMTS-4 were immunolocalized and the methylation status of
specific promoter CpG sites was determined. Both primary and secondary OA were characterized by loss of aggrecan, formation of clones, and
abnormal expression of the proteases that correlated with epigenetic DNA demethylation. The latter indicated that the abnormal expression
of the cartilage-degrading proteases was not due to a short-term up-regulation, but a heritable, permanent alteration in gene expression.
Comparing cell densities in young and old control cartilage estimated an age-related cell loss of1% per year. In aged #NOF cartilage, some
superficial-zone chondrocytes expressed the proteases, but the majority of cells were immunonegative and their promoters were
hypermethylated. The cellular and epigenetic features of the intermediate and deep zones of #NOF cartilage are thus similar to those of
young healthy cartilage, justifying the use of #NOF cartilage as control cartilage for OA, providing the superficial zone is removed.  2008
Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:593–601, 2009
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Osteoarthritis (OA) is characterized by defective
integrity of the articular cartilage and adjacent tissues
at diarthrodial joints.1,2 Primary OA has no obvious
predisposing cause, whereas for secondary OA factors
such as trauma or abnormal loading favor development
of the disease. Because primary OA occurs predom-
inantly in older people, age-related factors may be
involved, such as ‘‘wear and tear’’, oxidative stress,3 or
cellular senescence.4,5 However, OA is not a necessary
outcome of aging, as the disease also occurs in young
people. An example is developmental dysplasia of the hip
(DDH), a condition where the femoral head does not
develop correctly within the acetabulum. New-born
babies are generally screened for DDH so that problems
can be corrected by reduction using a Pavlik harness.6 In
some patients, however, the condition is not diagnosed
correctly during childhood or treatment fails to correct
the dysplasia. The resulting abnormal anatomy often
results in secondary OA at an early age, which requires
surgical treatment.7,8 We obtained OA cartilage from the
femoral head of a 23-year-old female DDH patient. This
provided a unique and rare opportunity to compare the
features of secondary OA in a young patient with those of
primary old-age OA and thereby delineate how age per se
influences OA. In addition, we obtained articular
cartilage from a 14-year-old male with spastic quad-
riplegia. This normal cartilage was compared with the
articular cartilage from osteoporotic patients, aged 80–
90 years, who had sustained a fracture (#) of the neck of
femur (#NOF). Because patients with osteoporosis rarely
have OA, and vice versa,9 the cartilage from #NOF
patients is frequently used as control cartilage for OA,
but to what extent is this justified?
The present study concentrated on the cellular and
epigenetic features of the various types of articular
cartilage, because these are central to the patho-etiology
of the disease. The cellular features are well estab-
lished.1,10,11 Briefly, chondrocytes change from anabolic
to catabolic cells that produce large quantities of matrix-
degrading enzymes, which include aggrecanases
(ADAMTS [a disintegrin and metalloproteinase with
thrombospondin motifs]-1, -4, and -5) and matrix metal-
loproteinases (MMP-1, -2, -3, -9, -13). We have previously
also established the epigenetic features of primary OA by
showing that the abnormal expression of MMP-3, -9, -13,
and ADAMTS-4 was associated with loss of DNA methyl-
ation at specific cytosine-phosphate-guanine (CpG)sites in
the promoters of the respective enzymes.12,13 DNA
methylation, together with histone modifications, are
epigenetic mechanisms that silence those genes that are
normally not expressed, thus assuring genomic stabil-
ity.14
The aims of the present study were: (i) to compare and
contrast the cellular and epigenetic features of the young
normal cartilage with those of aged #NOF cartilage; (ii)
to characterize the cellular features of OA in a young
DDH patient by histological comparison with primary
OA; and (iii) to determine whether the epigenetic
features that had previously been observed in primary
OA12 were also present in the young DDH patient.
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METHODS
Selection of Material
All samples were obtained with patients’ consent and the
approval of the local ethics committee.
Fourteen-Year-Old Male
This patient suffered from spastic quadriplegia and both hips
were neurologically dislocated. The patient was in great pain,
but surgical reconstruction was not indicated. Instead, the
proximal femur was excised, enabling us to obtain extremely
rare young cartilage for histology and DNA extraction.
DDH Patient
A Charnley total hip arthroplasty was performed on a 23-year-
old female for secondary OA following the sequelae of DDH.
Although she had had multiple surgical interventions, her hip
had failed, due to degenerative changes and subluxation. The
femoral head was severely deformed and osteophytes had
formed on both acetabulum and femoral head. Most of the bone
of the femoral head was used for bone grafting (Fig. 1), but
cartilage present in the circumference of a 1 cm thick slice of
the femoral head was available for histology and DNA
extraction. This is the first time that cartilage from a young
OA patient has been available for such studies.
Aged Patients
Femoral heads were obtained after arthroplasty for OA or
hemi-arthroplasty following a #NOF. This is an ongoing study,
with more than 30 patients in each group. Representative
examples were chosen for comparisons with the cartilage from
the 14 or 23 year old. For histology, cartilage was sampled from
both weight-bearing and non-weight bearing regions. For DNA
analyses, cartilage was sampled from the deep zones of #NOF
patients, but from the surface zones of OA patients, because, as
confirmed by histology, the former contained normal, healthy
chondrocytes, whereas the latter contained typical OA chon-
drocytes.
Histological Analyses
Full cartilage depth samples (4 10 mm) were dissected. To
label live/dead cells, the tissue pieces were incubated for 2–3 h
with the fluorescent marker CellTracker Green to label viable,
metabolically active cells, and with Ethidium homodimer-1 to
label dead or dying cells.15 Samples were fixed in 4%
paraformaldehyde, dehydrated with ethanols, cleared in
chloroform, and embedded in paraffin wax. Twenty-five to
forty sequential sections (7 mm) were cut and stored at 48C.
The distribution of fluorescent labels was viewed with a
LEICA TCS SP2 confocal laser-scanning microscope in
unstained sections without deparaffinization.
For other staining procedures, paraffin wax was removed.
Sections were stained with Safranin-O to identify regions of
proteoglycans, and with Weigert’s Haematoxylin/Alcian blue/
Sirius red to demonstrate better the regions of proteoglycan
loss, because Sirius red stains the cartilage collagen only in
those areas where proteoglycans are absent.16 Immunohisto-
chemistry was carried out with the following primary anti-
bodies: monoclonal antihuman MMP-3 (MAB3312; Chemicon)
and MMP-9 (MAB3309; Chemicon); rabbit antihuman MMP-13
(AHP751; Serotec, Oxford, UK) and ADAMTS-4 raised to the C-
terminal region (AHP821; Serotec) or to the disintegrin-like
domain (AB19165; Chemicon). Some sections were pretreated
with hyaluronidase (2 mg/mL in acetate buffer, pH 5, for 60 min
at 378C) to demonstrate matrix staining of the enzymes.
Sections were incubated with the primary antibodies overnight,
followed by biotinylated secondary antibodies (60 min) and
avidin-peroxidase (30 min) with 3-amino-9-ethyl-carbazole
(AEC) as the final chromogen. The slides were counterstained
briefly with 1% Alcian blue, mounted in glycerol jelly, and
viewed with a Zeiss Universal light microscope (Zeiss, Welwyn
Garden City, UK). Images were captured with a digital camera.
Cell Counting
To obtain an approximate estimate of the age-related loss
of chondrocytes, four to six representative sections of the
cartilage from the 14 year old and from aged #NOF patients
were photographed at a magnification of X100. The images
were transferred to a PowerPoint slide and enlarged so that
each image covered the slide fully and could be viewed with a
final magnification of X400. A grid consisting of 7 10 squares,
corresponding to an area of 280 400 mm was overlaid and the
cells were counted in each subsection grid. The numbers were
normalized to an area of 100 100 mm, the mean values and
standard deviations were calculated, and the two groups were
compared using the Student’s t-test.
Cell diameters were determined in images of representative
sections, transferred to a PowerPoint slide as above. The shortest
diameter of 40 small chondrocytes, located in the superficial
and intermediate zones, and 40 large chondrocytes, located
near the osteophyte, was measured in the same section, using
an image analysis program (Image J; NHI, Wayne Husband,
Bethesda, MD). The mean values and standard deviations were
calculated and the two groups were compared using the
Student’s t-test.
DNA Methylation Status
Genomic DNA was extracted directly from the human
cartilage samples after they were ground in a liquid nitro-
gen-cooled freezer mill and the methylation status of individ-
ual CpG sites in the promoters of MMP-3, -9, -13, and
ADAMTS-4 was determined with the aid of methylation-
sensitive restriction enzymes, followed by semi-quantitative
polymerase chain reaction (PCR), as previously described.12
RESULTS
Comparison of Young Versus Old Non-OA Cartilage
The femoral head obtained from the 14-year-old male
was deformed, but was covered evenly with smooth,
visually healthy cartilage. The femoral heads from
Figure 1. Sketch to illustrate position of the sampled 1 cm slice of
the femoral head obtained from the DDH patient.
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#NOF patients were also covered with healthy cartilage,
although some wear was sometimes seen in the weight-
bearing region and the histological features varied in
different #NOF patients. To illustrate the range, two
sets of images are shown that show the two extremes of
the observed features: (i) from non-weight bearing
regions that showed little or no degradation; and (ii)
from weight-bearing regions that showed early signs of
degradation. Because the staining characteristics of
intermediate and deep zones did not differ between the
non-weight bearing and weight bearing samples, the
images in Figures 2 and 3 are from the superficial zone
only.
As expected, the cartilage from the 14-year-old patient
had a smooth surface and good Safranin-O staining,
except for some loss at the very surface (seen at higher
magnification) (Fig. 2A). The surface of cartilage from
the non-weight bearing regions of #NOF patients was
smooth and its chondrocytes were flattened and aligned
with the surface (Fig. 2B,E, and insert in E), as would be
expected for normal cartilage. However, the surface of
the cartilage from the weight-bearing regions was
irregular (Fig. 2C,F), and the cells were rounded (insert
in Fig. 2F), suggesting that the zone of flattened cells had
been eroded. It is noteworthy that these cells were not
directly at the surface, because that region no longer
contained cells (Fig. 2F). Loss of proteoglycan near the
surface was more pronounced (Fig. 2B,C), as also seen in
Figure 2E,F.
Specimens from non-weight bearing regions had very
few dying cells and many cells near the surface were
metabolically active (Fig. 3A), whereas in weight-bear-
ing regions many chondrocytes near the surface were
dying or dead (Fig. 3B). Of the matrix-degrading
enzymes, only MMP-3 showed positive staining in the
14 year old (Fig. 2G). All specimens from #NOF patients
contained some cells that were immunopositive for all
matrix-degrading enzymes. In the non-weight bearing
regions, immunopositive cells were encountered rarely
(arrows), but their numbers increased in cartilage from
weight-bearing regions (compare Fig. 2H,L with
Fig. 2J,M and Fig. 3D,G with 3E,H). Immunopositive
chondrocytes were, however, present only at the surface
of the superficial zone, never in intermediate and deep
zones (not shown). The location of immunopositive cells
always closely matched the region of proteoglycan loss.
As expected, cell density was higher in the cartilage of
the 14-year-old, whereas the cartilage of #NOF patients
contained large acellular regions, presumably due to
chondrocyte death. In the grid of 280 400 mm2,
3459.5 cells were present in the 14-year-old cartilage,
while only 132 22 cells were counted in the #NOF
Figure 2. Comparison of the
superficial zones of articular carti-
lage from a 14-year-old male
(A,D,G,K) with that obtained from
osteoporotic patients following a
fracture of the neck of femur
(#NOF). Panels (B,E,H,L) show
examples of the smooth cartilage
from non-weight bearing regions,
while (C,F,J,M) were taken from
weight-bearing regions. (A–C) Loss
of Safranin O staining at the sur-
face demonstrates progressive loss
of proteoglycans illustrating the
effect of age and weight-bearing at
the joint surface. (D–F) Alcian
blue/Sirius red staining. The loss
of proteoglycan makes the cartilage
collagen accessible for Sirius red
staining so that the intense red
staining at the surface also demon-
strates proteoglycan loss. (G–J)
The thick arrows point to the
regions that are enlarged 2.4X in
the insets of (E) and (F). Immuno-
localization of MMP-3 and (K–M) of
MMP-9. MMP-3 was expressed by
chondrocytes in the 14 year old (G),
whereas MMP-9 (K) was absent.
For the patients with a #NOF, the
numbers of immunopositive cells
were always higher in the cartilage
from weight-bearing regions, but
a few chondrocytes were always
immunopositive even in the non-
weight bearing regions. The thin
arrows point to single immunopos-
itive cells that are seen in higher
magnification in the insets (2.8X
enlargement in H and 3.1X in L
relative to the main image). Bar¼
25 mm. All main images are of the
same magnification.
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specimens (p< 0.001). Normalization to a surface of
100 100mm2 gives an estimate of 31 cells/0.01 m2 for the
14 year old, compared with 12 cells/0.01 m2 in the aged
controls.
Early Stages of OA in DDH Patient
In primary OA, the various stages of cartilage degrada-
tion (as evaluated by Osteoarthritis Research Society
International (OARSI) grading17) can be identified in
different regions of the femoral head. Cartilage sampled
near the weight-bearing regions always has a higher
score than cartilage from non-weight bearing regions.
Similarly, by sampling from different regions, it was
possible to identify different histological stages of OA in
the DDH patient. However, the total specimen consisted
only of a femur slice that was 1 cm thick, sampled near
the femoral neck. This region is non-weight bearing and
would show little evidence of erosion in most patients
with primary OA. However, the cartilage from the DDH
patient showed various degrees of erosion. In the area
seen in Figure 4A, an early osteophyte is seen on the left
and full-thickness cartilage on the right. The surface of
the full-thickness cartilage was mostly smooth and not
much proteoglycan had been lost. The density of the
cells was high (Fig. 4B–E), similar to that seen in the
14 year old. This cartilage may therefore be at an early
stage of erosion (or at least at an earlier stage than the
cartilage shown in Fig. 5). However, unlike the cartilage
from low-grade primary OA, the incidence of cell death
was high, particularly in the superficial region
(Figs. 4B,C). However, not all cells were dying. In some
regions, the chondrocytes were highly active, as shown
by the intense CellTracker green fluorescence (Fig. 4E).
Moreover, close proximity of two or more cells (arrows in
Fig. 4E) was consistent with the notion that the
surviving chondrocytes proliferated.
Immunostaining of parallel sections for MMP-3
(Fig. 4D), MMP-9 (Fig. 4F), and the other proteases
(not shown) showed that almost all chondrocytes
expressed proteases. Enzyme activity was also detect-
able in the matrix near the surface of the cartilage
(Fig. 4D), suggesting secretion of the enzymes. It is
noteworthy that the chondrocytes located near the
osteophyte were considerably larger than the chondro-
cytes in the superficial and intermediate zones (compare
Fig. 4G and 4H). The average diameter of chondrocytes
in the superficial and intermediate zones was 4.2
1.1 mm and that of the large chondrocytes was 16.5
2.5 mm (p<0.001). This three- to fivefold enlargement is
consistent with the interpretation that these cells had
further differentiated to hypertrophy prior to osteophyte
formation via endochondral ossification. No typical
clusters/clones of primary OA were seen in this section.
Late Stages of OA in the DDH Patient
Cartilage specimen from a different region resembled
specimens from high-grade OA. Proteoglycans had been
lost from the upper third of the tissue (Fig. 5A,B).
The surface was highly fibrillated and had a fibrous
appearance. The latter may have resulted from fibrous
overgrowth that can sometimes be observed in primary
OA specimens. However, the latter tends to be demar-
cated by a layer of dense cells in the overlying fibrous
tissue (see Fig. 5C), which was not seen in the DDH
sample, whose cartilage matrix was continuous with
the fiberlike superficial zone, with only few cells in
this upper region (Fig. 5D,E). These remaining few
Figure 3. Live/dead staining in
the superficial zone of the non-
weight-bearing region (A) shows
mostly viable cells, but the inci-
dence of cell death is higher in the
weight-bearing regions (B). Cells
below the surface do not show
fluorescence (*), indicating that
they have low metabolic activity.
No expression of the proteases
MMP-13 or ADAMTS-4 was found
in the 14 year old (C,F). For the
patients with a #NOF, the number
of immunopositive cells was always
higher in the cartilage from weight-
bearing regions, but a few chondro-
cytes were always immunopositive
even in the non-weight bearing
regions. Compare (D,E) for MMP-
13 and (G,H) for ADAMTS-4. The
arrows point to those cells that are
seen in higher magnification in the
inset. Arrowheads point to other
immunopositive cells. Bar¼25 mm.
All images are of the same magni-
fication.
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cells were metabolically active and immunopositive
for MMP-3 (Fig. 5F), ADAMTS-4 (Fig. 5G), MMP-9
(Fig. 5H), and MMP-13 (not shown). Significant enzyme
activity was also present in the matrix throughout
the upper fibrous regions. Ongoing cell death occurred
predominantly in chondrocytes in the upper cartilage/
lower fibrous region (Fig. 5D,E).
This sample of DDH cartilage also contained the
typical clones of OA cartilage. The cells of the clones were
viable (Fig. 6A) and expressed MMP-3, MMP-9, MMP-
13, and ADAMTS-4 (Fig. 6B–E). These characteristics
matched those in primary OA (Fig. 6F–K).
Evaluation of DNA Methylation Status
As virtually all chondrocytes of the DDH patient
expressed proteolytic enzymes, it was of interest to
investigate whether this abnormal expression was
associated with an ‘‘unsilencing’’ via DNA demethyla-
tion, as had been shown for primary OA.12 Figure 7
illustrates the DNA methylation status of specific CpG
sites in the promoters of the four proteases for each of
the four cartilage specimens. Consistent with absence of
MMP-13 expression, bands were present at all exam-
ined CpG sites in the MMP-13 promoter in the two
control cartilage specimens, although the band intensity
was reduced at 134 in the #NOF patient. In our
previous study we also found a reduced or absent band
at this site in 3/10 #NOF patients. Not all CpG sites are
equally important for silencing and we had previously
shown that it was loss of DNA methylation at the CpG
site at 110 bp that was the most critical for ‘‘unsilenc-
ing’’ of MMP-13.12 Indeed, in both aged OA and the
DDH patient, loss of DNA methylation had occurred at
both 134 bp and 110 bp with an additional loss at
14 bp in the DDH patient. For MMP-9, the CpG sites
at 712 bp and at least one of the two sites at 624 and
562 bp were hypo-methylated in all specimens in
agreement with previous findings, suggesting that these
sites play a minor role in transcriptional silencing. By
contrast, the CpG sites close to the transcription start
were demethylated in both primary OA and DDH
samples, but not in the controls. These sites, therefore,
were most likely involved in transcriptional silencing in
healthy cartilage. For MMP-3, there was a marked
difference between the #NOF control samples, whose
CpG sites were methylated throughout, correspond-
ing to absence of MMP-3 expression, and those of the
14-year-old patient, where there was no methylation
at 1923 bp and considerable loss of methylation at
635 bp. In both OA and the DDH samples it was the
same CpG sites that showed absence or considerable
Figure 4. Example of an osteo-
phyte and lower grade OA in the
DDH patient (OARSI grade 1–2).
(A) Alcian blue/Sirius red-stained
overview of the section, showing
thick cartilage (blue) and a bony
osteophyte (red) on the left. (B,C)
Live-dead staining with Cell-
Tracker green and Ethidium homo-
dimer-1 demonstrates a high
incidence of cell death (red) as well
as some metabolically active cells
(green). (D) MMP-3 immunostain-
ing in the same region as that shown
in (C) illustrates that most chondro-
cytes produced the protease (brown
stain). In a different area (E), viable
(green) cells were closely approxi-
mated, suggestive of cell division
(arrows). Near the osteophyte (F),
the size of the chondrocytes had
increased three- to fivefold (G,H)
and nearly all cells were immuno-
positive for MMP-9. Bars¼ 500 mm
in (A), 50mm in (B–E), 150mm in (F),
and 25 mm in (G,H).
CELLULAR AND EPIGENETIC FEATURES OF YOUNG HEALTHY AND OA CARTILAGE 597
JOURNAL OF ORTHOPAEDIC RESEARCH MAY 2009
reduction in methylation. For ADAMTS-4, both OA
samples showed loss of DNA methylation at the CpG
sites located between 232 and 829 bp. Data on the
methylation status of the ADAMTS-4 sites were not
available for the 14-year-old patient.
Overall, there was a good correlation between induc-
tion of expression of the typical OA proteases and loss of
DNA methylation in the relevant promoter regions. The
DNA methylation status of the samples from the 14-year-
old patient was identical to that of the aged #NOF
Figure 5. Features of high-grade
OA in the DDH patient (OARSI
grade 4). (A,B) Composite images
to show an overview of the
whole section. Comparison of
the Alcian blue/Sirius red
stained section (A) with the Safra-
nin O stained section (B) clearly
illustrates the loss of proteoglycan.
(C) The typical appearance of
fibrous overgrowth in idiopathic
OA. The demarcation between car-
tilage and fibrous overgrowth is
clearly seen. (D,E) The fiberlike
region at the surface of the DDH
patient. The few cells that remain
in the fiberlike region are viable
(green), but dead cells (red) are
present in the upper cartilage zone.
(F–H) Extensive protease activity
in almost all chondrocytes and in
the matrix. This is illustrated for
MMP-3 (F), ADAMTS-4 (G), and
MMP-9 (H). The sections had been
pretreated with hyaluronidase,
which uncovers binding sites in
the matrix (brown stain). Bars¼
500 mm in (A,B); 50 mm in (C–E)
and (H); and 200 mm in (F,G).
Figure 6. The typical cell clus-
ters of severe OA cartilage in the
DDH patient (A–E) and in late-
stage primary OA (F–K). (A,F)
Live-dead staining demonstrates
that most cells are viable and meta-
bolically active (bright green fluo-
rescence), although some cell death
is also apparent (red cells in F). All
the cells within a clone are immuno-
positive for MMP-3 (B,G), MMP-9
(C,H), MMP-13 (D,J), and
ADAMTS-4 (E,K), illustrating the
similarity between OA in the young
DDH patient with that in old-age
idiopathic OA.
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patients, except for MMP-3. The DNA methylation
pattern in the DDH patient was similar, but not
identical, to that previously observed in primary OA.12
DISCUSSION
Joint replacement operations not only give a new lease
on life to elderly patients with OA, but their discarded
femoral heads or knee joints provide researchers with
articular cartilage. Non-OA cartilage becomes available
when, as a result of osteoporosis, patients who had
sustained a #NOF undergo hemi-arthroplasty. Patients
with osteoporosis generally do not have OA,9 which
makes possible the use of cartilage from #NOF patients
as control for studies of OA cartilage. This study
determined whether it is valid to do so.
Age is a known risk factor for primary OA, but to what
extent does age per se contribute to the disease process?
To throw light on this question the cellular and
epigenetic features of old-age primary OA were com-
pared with those of a 23-year-old patient who had OA
following failed treatment for DDH.
Differences between Young and Old-Age Control Cartilage
The first age-related change was a reduction in cell den-
sity from 31 to 12 cells/0.01 mm2 in the 80–90-year-
old cartilage; this suggests a net loss of60% of the cells
over a period of six to seven decades. Cell density results
from the difference between proliferation and apoptosis.
Proliferation exceeds apoptosis during skeletal growth,
but is reduced considerably after maturity. If cell
density at skeletal maturity (at 18 years) approxi-
mates that of the 14 year old and if chondrocytes in
adult life divide infrequently, the age-related rate of
cell death would be 1% per year, a rate similar to
the incidence of chondrocyte death estimated by Aigner
et al.18
The second age-related feature was production of
proteolytic enzymes by some chondrocytes in the super-
ficial zone of #NOF cartilage. Of the four enzymes
examined, only MMP-3 was expressed by chondrocytes
in the 14 year old and only MMP-3 showed loss of DNA
methylation in the MMP-3 promoter. Conceivably,
remodeling of the growing cartilage requires only
MMP-3, but not MMP-9, MMP-13, or ADAMTS-4. This
inference is supported by reports that MMP-3 modulates
remodeling in the physis of calves19 and in articular and
proliferating chondrocytes of fetal rabbits.20 On the other
hand, it is possible that low concentrations of inflamma-
tory cytokines in the synovium of this spastic quad-
riplegia patient activated MMP-3 more than the other
degradative enzymes.
Is Cartilage from Osteoporotic Patients a Suitable Control
for OA?
Microscopic examination revealed variability both
between patients and within the same femoral head.
The observation that some chondrocytes of the super-
ficial zone expressed proteases indicated caution in the
indiscriminate use of #NOF cartilage as a control.
However, because protease-positive chondrocytes were
clearly confined to the superficial zone and to weight-
bearing areas, cartilage from intermediate and deep
zones of #NOF patients does indeed constitute suitable
control cartilage, at least with regards to the parame-
ters examined in the present study.
Cellular and Epigenetic Features of Young and Old-Age OA
The histology of the cartilage from the 23-year-old DDH
patient was striking in showing how far the disease had
advanced in this young patient. This was especially so
Figure 7. Methylation status at CpG sites in the promoters of
MMP-3, MMP-9, MMP-13, and ADAMTS-4 for a typical #NOF
patient, the 14-year-old control patient, a representative OA
patient, and the 23-year-old DDH patient. The data for the #NOF
patient and old-age OA patient are not new, but shown to enable
comparison with the young patients. DNA was treated with the
listed methylation-sensitive restriction enzymes, which cleave at
the indicated locations if the CpG site(s) are not methylated. Hence
presence of bands indicates methylation and vice versa. A weak
band indicates absence of methylation in most, but not all
chondrocytes. The first band of each primer pair shows the PCR
for the DNA control, that is, not treated with enzyme. This band
represents a check for DNA loading, to ensure that absence of a band
is not due to an insufficient amount of DNA. AciI often cleaved
several CpG sites within the amplicon of the PCR primers; these
were assessed together. The DNA methylation pattern for the old-
age #NOF patient was similar to that of the 14 year old, except for
MMP-3. The DDH patient showed a similar loss of DNA methyl-
ation as the OA patient. The primers M9d show spurious bands; the
relevant band is at 400 bp. Similarly, the primers used for the two
OA samples show an additional band; the relevant is the lowest
band at 400 bp. For the #NOF patient and the 14 year old this
primer pair was replaced by different primers bracketing the same
AciI-cleavable region, hence the absence of spurious bands.
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because the cartilage had been sampled near the
femoral neck, where OA patients still have healthy
cartilage, even if the cartilage at the weight-bearing
region has been eroded. Although disease progression
varies considerably from patient to patient, it generally
takes decades for cartilage to become completely eroded.
The age when arthritis started in the DDH patient is not
known, but cartilage with an OARSI grade of 4 indicates
a very advanced stage of the disease after at most two
decades.
The fact that almost all chondrocytes, not only those in
the superficial zone, were enzyme-producing cells is a
further indication of how far the disease in this young
patient had advanced. Because vast regions were devoid
of cells, large numbers of chondrocytes had been
eliminated, probably by ‘‘chondroptosis’’, which leads to
autophagocytosis and regions that are acellular.21 How-
ever, those chondrocytes that survived had formed
clones, consistent with cell proliferation. This was as
true for the diseased cartilage of the DDH patient
cartilage as for the cartilage from primary OA. All cells
in the clones of the DDH patient as well as aged OA
patients were immunopositive for proteases which, upon
release into the matrix, could contribute to degradation
of the matrix. The expression of proteolytic enzymes in
the chondrocytes of the DDH patient was always
associated with loss of DNA methylation at specific
CpG sites in the promoter regions, just as it had been for
primary old-age OA, suggesting that age cannot be the
sole explanation for the epigenetic ‘‘unsilencing’’ that
occurs in OA.
Some protease-positive chondrocytes sited near the
subchondral bone were three to five times larger than
chondrocytes in a more distal site. This is consistent with
hypertrophic differentiation, which has been proposed as
a possible explanation for the changed OA phenotype,
based on the observation that chondrocytes near the
calcified cartilage of OA patients are immunopositive for
type X collagen.22,23 However, such an increase in cell
size was only observed near the osteophyte, not in other
cartilage sections from the DDH patient, nor have we
observed it in primary OA cartilage. This suggests that
the hypertrophy is related to the osteophyte formation by
endochondral ossification rather than being a general
phenomenon of OA cartilage.
There are several caveats that should be borne
in mind. We only had access to one specimen of young
healthy cartilage and one young OA patient, because
these are only rarely available. Due to restrictions in the
UK it is almost impossible to obtain postmortem femoral
heads from young patients. With improved detection and
correction of DDH in childhood, it is highly unlikely that
we shall be able to obtain OA cartilage from another DDH
patient. To the authors’ knowledge, no other studies have
investigated the histological or epigenetic character-
istics of OA cartilage in a young patient. We believe that
this study provides valuable data that increase our
understanding of the patho-etiology of OA, even if based
on only one patient.
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